Clinical Trial: Pharmacokinetics of Petrelintide in Participants With Impaired Hepatic Function

U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07682818) titled 'Pharmacokinetics of Petrelintide in Participants With Impaired Hepatic Function' on June 26.

Brief Summary: This clinical research trial is testing the investigational medicinal product (IMP) petrelintide that is being developed for body weight reduction in people living with obesity or overweight who have comorbidities.

The aim of this clinical research trial is to investigate whether the pharmacokinetics (PK) of petrelintide will be different in people with hepatic impairment (HI) compared to people with normal hepatic function.

Study Start Date: May 18

Study Type: INTERVENTIONAL

Condition: Impaired Hepatic Function

Intervent...